stella
beta
Vemurafenib and Cobimetinib for the Treatment of Patients With High Risk Differentiated Thyroid Carcinoma With BRAFV600E Mutation — Stella
Recruiting
Back to Thyroid Gland Follicular Carcinoma trials
Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations
(1 site)
United States
City of Hope Medical Center, Duarte, California
View full record on ClinicalTrials.gov